I am 37, male. How to manage IBS-D and hepatitis?

Question

Hi doctor,

I am a 37-year-old woman who has been dealing with IBS-D for several years, and I was diagnosed with autoimmune hepatitis about a year ago. I follow a careful diet to manage my IBS, but I still experience frequent episodes of diarrhea, cramping, and bloating, which have become more unpredictable since starting immunosuppressive treatment for my liver condition. At times, it is difficult to tell whether my symptoms are due to an IBS-D flare or if the autoimmune hepatitis or its treatment is contributing.

I have also noticed increased fatigue and occasional nausea, which makes it challenging to maintain a consistent eating routine. I am concerned that my gut health may be affecting my liver health, or vice versa, and I feel stuck in a cycle where treating one condition seems to aggravate the other. Given that I have both IBS-D and autoimmune hepatitis, is there a recommended approach to managing both conditions together without worsening either one?

Please help.

Answer 1

Hi,

Welcome to icliniq.com.

I understand your concern.

Managing irritable bowel syndrome with diarrhea (IBS-D) alongside autoimmune hepatitis (AIH) can be challenging, but both conditions can be controlled together with a coordinated approach. Importantly, IBS-D is a functional gut–brain interaction disorder, whereas autoimmune hepatitis is an immune-mediated liver disease. One condition does not directly damage the other; however, treatments, stress, and physiological changes can overlap and influence symptoms.

Immunosuppressive medications used for autoimmune hepatitis, such as corticosteroids or Azathioprine, can affect gut motility, alter the intestinal microbiota, and interfere with bile acid handling. These effects may worsen diarrhea, bloating, or nausea and make IBS symptoms more unpredictable. Fatigue and nausea may also result from liver inflammation, medication side effects, or nutritional imbalances rather than IBS alone.

Key management principles are:

Periodically rule out organic causes of diarrhea, including stool infections, fecal calprotectin (to assess intestinal inflammation), bile acid diarrhea, celiac disease, and medication-related side effects. Not all diarrhea in patients with autoimmune hepatitis is due to IBS.
Optimize control of autoimmune hepatitis first, as active liver inflammation can worsen gastrointestinal symptoms and fatigue. Stabilization of liver enzyme levels often improves overall gastrointestinal tolerance.
IBS-D–specific treatment should be gentle and liver-safe, including dietary modifications such as a low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (low-FODMAP) diet under professional guidance, soluble fiber supplementation, antispasmodic medications, gut-directed probiotics, and stress-management strategies.
Avoid unnecessary antibiotics or harsh laxatives, as these can aggravate both IBS symptoms and liver health.
Monitor nutritional status closely to prevent unintended weight loss and vitamin or mineral deficiencies.

A combined hepatology and gastroenterology follow-up is ideal. With careful medication selection, balanced dietary management, and symptom-based treatment, most patients can achieve good control of both conditions without one worsening the other.

I hope this has helped you.

Please feel free to reach out to me again for further queries.

Thank you.